Global Computer Aided Diagnostics (CADx) Market - Analysis and Forecast 2017-2025 - Focus on Application, Imaging Modalities, Country Analysis, Patent Landscape, Market Share Analysis and Competitive Landscape

  • ID: 4334094
  • Report
  • Region: Global
  • 339 pages
  • BIS Research
1 of 7
The Global Computer Aided Diagnostics Market is Forecast to Reach $1.3 Billion by 2025

FEATURED COMPANIES

  • Agfa Healthcare
  • EDDA Technology, Inc
  • Hologic Inc
  • Invivo Corporation
  • McKesson Corporation
  • Merge Healthcare Inc
  • MORE

The computer aided diagnostics (CAD) have emerged as one of the major potential tools in the medical imaging and diagnostic radiology. The performance and interpretation of diagnostic radiology test is a complex process, since handling and interpretation of the large volume of medical data and images can lead to increasing chances of interpretation errors by the radiologists. However, the solution to the prevention of these errors is the usage of computer aided diagnostics (CAD), along with several imaging modalities, in order to analyse and interpret medical images more accurately and precisely. The primary factors associated with the usage of CAD solutions are decreased false negative rate, accurate detection of cancer at an early stage, increased specificity and sensitivity of the diagnostics tests, improved intra- and inter-reader variability and reduced mortality rates.

This research study includes an extensive analysis of the global computer aided diagnostics (CAD) market, by application, diagnostics modalities and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. Each of these segments has been analyzed on the basis of their current and future market size, considering the macro and micro environmental factors.

The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key market participants. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, competitive benchmarking, and the position of the competitors within the global computer aided diagnostics (CAD) market.

With the advent of speech recognition software and computer aided diagnostics (CAD), the replacement of radiologists by computers has been swirling around for years. The introduction of deep learning and machine intelligence has re-ignited this discussion and the industry leaders are discussing what might happen in the upcoming 20 years. Handling and interpretation of the large volume of medical data and images can lead to an increasing chances of errors by a radiologist. Several tasks in radiology are extremely difficult, such as finding small lesions among several layers of fibro glandular breast tissues. The other tasks can be time consuming such as reviewing a large number of MRI or CT slices. However, the intent of CADx solutions is to aid the radiologists to perform the tasks more effectively and accurately with greater safety and speed.

The computer aided diagnostics (CAD) is a concept established by equally taking into account the roles of physicians and computers. It is based on a computer algorithm (deep learning) which serves as “second reader” or “second opinion” in making the final decisions by the radiologists in the analytics and interpretations of huge collection of medical data. This technique of CADx helps the radiologists in accurately interpreting the images and identify the potential findings to avoid incorrect interpretations or overlooking of lesions.

The rising incidence of various types of cancer, such as breast, lung, prostate and colorectal, cancer is the primary responsible factor for the growth of CADx market. Furthermore, advancements in digital imaging techniques, improved efficiencies of CADx solutions, ease of integration of CADx solutions with various imaging equipment and growing awareness among the patients about early detection of cancer, have boosted the overall growth of this market. Moreover, the expansion of CADx applications to newer clinical areas, active research and development activities in medical imaging, rapid transition of hospitals to promote automatic workflow integration in their current work environment and rising installation base of CADx solutions in various multi-specialty hospitals, is further expected to accentuate the growth of this market in the near future.

According to a report titled ‘Global Computer Aided Diagnostics (CADx) Market - Analysis and Forecast (2017-2025)’, the global computer aided diagnostics market is forecast to reach $1.3 billion by 2025. The CADx market broadly focuses on major application areas (oncology, cardiovascular, and neurological) and various imaging modalities (mammography, MRI, tomosynthesis, etc.). The oncology segment is further sub-segmented into breast, lung, colorectal, prostate, liver and other cancer. The breast cancer acquired the highest market value in 2016, growing at a CAGR of 10.7% and is anticipated to reach $715.9 smillion in 2025. However, prostate cancer is growing at the highest CAGR. The reason for such a strong market share is attributed to the rising incidence of breast cancer.

The following key questions have been addressed in the report:

  •  What are the major market drivers, challenges and opportunities of the global computer aided diagnostics market?
  •  How the global computer aided diagnostics (CAD) market is evolving during the forecast period?
  •  What are the driving and restraining factors in the global computer aided diagnostics (CAD) market?
  •  What are the market shares of the leading segments and sub-segments of the global computer aided diagnostics (CAD) market in 2016 and 2025?
  •  How will each segment of the computer aided diagnostics (CAD) market grow over the forecast period and how much revenue will these account for in 2025?
  •  How will the market share of the leading companies change in 2017 and which country will lead the market in 2017?
  •  How will the industry evolve during the forecast period between 2017 and 2025?
  •  What are the key developmental strategies implemented in different types across all regions?
  •  Which geographical region will lead the global computer aided diagnostics market by the end of the forecast period?
  •  What are the market trends and key developments in this market?

The report includes the profiles of the major players in the market that allows the readers to get an insight into the various industry trends.  Some of the leading companies in the market are iCAD Inc., Hologic Inc., EDDA Technology, Inc., GE Healthcare, Merge Healthcare Inc., Siemens Healthcare, Agfa-Gevaert N.V., Fujifilm Medical Systems, Philips Healthcare, Samsung Medison, Neusoft Corporation, Invivo Corporation, Cadens Medical Imaging, Riverain technologies, Median Technologies and McKesson Corporation.

READ MORE
Note: Product cover images may vary from those shown
2 of 7

FEATURED COMPANIES

  • Agfa Healthcare
  • EDDA Technology, Inc
  • Hologic Inc
  • Invivo Corporation
  • McKesson Corporation
  • Merge Healthcare Inc
  • MORE

Executive Summary

1 Report Scope and Methodology
1.1 Scope of the Report
1.2 Global Computer Aided Diagnostics Market Segmentation
1.3 Key Learnings
1.4 Research Methodology
1.4.1 Data Triangulation 
1.4.2 Key Data Points From Secondary Sources
1.4.3 Key Data Points From Primary Sources
1.4.4 Top-Down Approach (Segmental Analysis)
1.4.5 Bottom-Up Approach (Segmental Analysis)
1.4.6 Assumption and Limitations
1.4.7 Data and Prediction Modelling

2 Market Overview
2.1 Introduction
2.2 Market Trend
2.3 Evaluation method for CAD
2.4 Involvement of Deep Learning in CADx
2.5 CADx Deep Learning need in Radiology
2.6 Advantages of Computer Aided Diagnostics
2.7 Some Restraining Factors in Widespread Adoption of CADx Deep Learning Algorithm 
2.8 CADx-Recent Developments

3 Market Dynamics
3.1 Overview
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Challenges
3.5 Market Opportunities

4 Competitive Landscape
4.1 Key Market Development Snapshot
4.1.1 New Product Launches, Developments and Testing
4.1.2 Patents, Approvals and Certifications 
4.1.3 Mergers and Acquisitions
4.1.4 Collaborations, Joint Ventures & Partnerships
4.1.4 Business Expansion
4.1.5 Others Strategies
4.2 Technological Trend
4.3  Legal Requirements and Regulations
4.4 Supply Chain Analysis

5 Industry Insights
5.1 Patent Landscape
5.2 Consortiums, Associations and Regulatory Bodies

6 Global CADx Market by Applications
6.1 Overview
6.2 Oncology
6.2.1 Breast Cancer
6.2.2 Lung Cancer
6.2.3 Colorectal Cancer
6.2.4 Prostate Cancer
6.2.5 Liver Cancer
6.2.6 Other Cancers
6.2 Other Diseases

7 Global CADx Market by Imaging Modalities
7.1 Overview
7.2 Mammography
7.3 Magnetic Resonance Imaging (MRI)
7.4 Ultrasound
7.5 Tomosynthesis
7.6 Computed Tomography (CT)
7.7 Others

8 Global CADx Market by Geography
8.1 Overview
8.2 North America
8.2.1 The U.S.
8.2.2 Canada
8.3 Europe
8.3.1 The U.K.
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Poland
8.3.7 Netherlands
8.3.8 Switzerland
8.3.9 Austria
8.3.10 Rest of Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 South Korea
8.4.5 Australia
8.4.6 India
8.4.7 Rest of APAC
8.5 RoW
8.5.1 Brazil
8.5.2 Russia
8.5.3 Rest of RoW

9 Company Profiles
9.1 Cadens Medical Imaging
9.1.1 Overview
9.1.2 Product Mapping
9.1.3 Financials
9.1.3.1 Financial Summary
9.1.4 SWOT Analysis
9.2 EDDA Technology, Inc.
9.2.1 Overview
9.2.2 Product Mapping
9.2.3 Overall Summary
9.2.3 SWOT Analysis
9.3 Fujifilm Holdings Corporation
9.3.1 Overview
9.3.2 Product Mapping
9.3.3 Financials
9.3.3.1 Financial Summary
9.4 GE Healthcare
9.4.1 Overview
9.4.2 Financials
9.4.2.1 Financial Summary
9.4.3 SWOT Analysis
9.5 Hologic Inc.
9.5.1 Overview
9.5.2 Product Mapping
9.5.3 Financials
9.5.3.1 Financial Summary
9.5.4 SWOT Analysis
9.6 iCAD Inc.
9.6.1 Overview
9.6.2 Product Mapping
9.6.3 Financials
9.6.3.1 Financial Summary
9.6.4 SWOT Analysis
9.7 Invivo Corporation
9.7.1 Overview
9.7.2 Product Mapping
9.7.2 SWOT Analysis
9.8 Koninklijke Philips N.V.
9.8.1 Overview
9.8.2 Product Mapping
9.8.3 Financials
9.8.3.1 Financial Summary
9.8.4 SWOT Analysis
9.9 Median Technologies
9.9.1 Overview
9.9.2 Product Mapping
9.9.3 Financials
9.9.3.1 Financial Summary
9.9.4 SWOT Analysis
9.10 Merge Healthcare Inc.
9.10.1 Overview
9.10.2 Product Mapping
9.10.3 Financials
9.10.3.1 Financial Summary
9.10.4 SWOT Analysis
9.11 Neusoft Corporation
9.11.1 Overview
9.11.2 Product Mapping
9.11.3 Financials
9.11.3.1 Financial Summary
9.11.4 SWOT Analysis
9.12 Parascript LLC
9.12.1 Overview
9.12.2 Product Mapping
9.12.3 Overall Summary
9.12.4 SWOT Analysis
9.13 Riverain Technologies 
9.13.1 Overview
9.13.2 Product Mapping
9.13.3 Overall Summary
9.13.4 SWOT Analysis
9.14 Samsung Medison Co. Ltd.
9.14.1 Overview
9.14.2 Product Mapping
9.14.3 Financials
9.14.3.1 Financial Summary
9.14.4 SWOT Analysis
9.15 Siemens Healthineers 
9.15.1 Overview
9.15.2 Product Mapping
9.15.3 Overall Summary
9.15.4 SWOT Analysis
9.16 Agfa Healthcare
9.16.1 Overview
9.17 McKesson Corporation
9.17.1 Overview
9.18 Xinapse Systems Ltd
9.18.1 Overview

LIST OF TABLES
1 New Product Launches, Developments and Testing
2 Patents, Approvals and Certifications
3 Mergers and Acquisitions
4 Collaborations, Joint Ventures & Partnerships
5 Business Expansions
6 Other Strategies
7 Technological Trend-Some of the FDA approved CADx
8 Supply Chain Analysis
9 Patent Landscape
10 Consortiums, Associations and Regulatory Bodies
11 Some of the Commercialized Mammography CADx Systems
12 Some of the CADx System for Lung Cancer
13 Some of the CADx System for Colorectal Cancer
14 Europe: Key Players

LIST OF FIGURES
1 CADx Drivers & Challenges
2 Global CADx Market Share by Application, 2016
3 Global CADx Market Share by Application, 2025
4 Global CADx Application Market Growth Rate (CAGR, 2017-2025)
5 CADx Market Share by Imaging Modalities, 2016
6 CADx Market Share by Imaging Modalities, 2025
7 Global CADx Imaging Modalities Market Growth Rate (CAGR, 2017-2025)
8 Top Computer Aided Diagnostics Market and Growth Rate (CAGR, 2017-2025)
9 Global CADx Market by Countries Growth Rate (CAGR, 2017-2025)
10 Global CADx Market Value by Geography, 2016 & 2025 ($Million)
11 Global CADx Market Share by Geography, 2016
12 Global CADx Market Share by Geography, 2025
13 Global CADx Market by Geography Growth Rate (CAGR, 2017-2025)
14 Global Computer Aided Diagnostics Market Segmentation
15 Research Methodology
16 Data Triangulation
17 Key Data Points From Secondary Sources
18 Secondary Data Sources
19 Key Data Points From Primary Sources
20 Top-Down Approach (Segmental Analysis)
21 Bottom-Up Approach (Segmental Analysis)
22 Assumptions and Limitations
23 Data and Prediction Modelling
24 The Four Major Components of CADx Scheme
25 CADx System Installation Data
26 Market Trend
27 CADx Deep Learning Need in Radiology
28 Advantages of Computer Aided Diagnostics
29 Market Dynamics
30 Market Drivers
31 Market Challenges
32 Market Opportunities
33 Recent Market Development Strategy Snapshot Analysis
34 Key Market Developments & Strategies
35 Global CADx Market by Application
36 Global CADx Market by Application, 2016-2025
37 Global CADx Application Market by Type, 2016-2025
38 Global CADx Oncology Application Market  2016-2025 ($Million)
39 Global CADx Other Diseases Application Market  2016-2025 ($Million)
40 Breast Cancer Application CADx Market, 2016-2025 ($Million)
41 Global CADx Lung Cancer Application Market 2016-2025 ($Million)
42 Global CADx Prostate Cancer Application Market, 2016-2025 ($Million)
43 Global CADx Liver Cancer Application Market, 2016-2025 ($Million)
44 Global CADx Other Cancers Application Market, 2016-2025 ($Million)
45 Global CADx Other Diseases Application Market 2016-2025 ($Million)
46 Neurological Indications
47 Global CADx Market by Imaging Modalities
48 Global CADx Market by Imaging Modalities, 2016-2025 ($Million)
49 MRI & CT Scan Volume data, 2015
50 Global CADx Mammography Market, 2016-2025 ($Million)
51 Mammogram Screening Reported, 2014-2015
52 APAC Mammogram Units Reported, 2014
53 U.S. Breast Screening Data
54 Global CADx Magnetic Resonance Imaging Market, 2016-2025 ($Million)
55 Global CADx Ultrasound Imaging Market, 2016-2025 ($Million)
56 Global CADx Tomosynthesis Market, 2016-2025 ($Million)
57 Global CADx Computed Tomography (CT) Market, 2016-2025 ($Million)
58 Global CADx Other Imaging Modalities Market, 2016-2025 ($Million)
59 Common Types of Nuclear Medicine Imaging
60 Global Computer Aided Diagnostics Market by Geography
61 Global CADx Market by Geography, 2016-2025 ($Million)
62 North America CADx Market, 2016-2025 ($Million)

Note: Product cover images may vary from those shown
3 of 7

Loading
LOADING...

4 of 7

FEATURED COMPANIES

  • Agfa Healthcare
  • EDDA Technology, Inc
  • Hologic Inc
  • Invivo Corporation
  • McKesson Corporation
  • Merge Healthcare Inc
  • MORE

With the advent of speech recognition software and computer aided diagnostics (CAD), the replacement of radiologists by computers has been swirling around for years. The introduction of deep learning and machine intelligence has re-ignited this discussion and the industry leaders are discussing what might happen in the upcoming 20 years. Handling and interpretation of large volume of medical data and images can lead to an increasing chances of errors by radiologist. Several tasks in radiology are extremely difficult, such as finding small lesions among several layers of fibro glandular breast tissues. The other tasks can be time consuming such as reviewing a large number of MRI or CT slices. However, the intent of CADx solutions is to aid the radiologists to perform the tasks more effectively and accurately with greater safety and speed.

The computer aided diagnostics (CAD) is a concept established by equally taking into account the roles of physicians and computers. It is based on computer algorithm (deep learning) which serves as “second reader” or “second opinion” in making the final decisions by the radiologists in the analytics and interpretations of huge collection of medical data. This technique of CADx helps the radiologists in accurately interpreting the images and identify the potential findings to avoid incorrect interpretations or overlooking of lesions.

The rising incidence of various types of cancer such as breast, lung, prostate and colorectal, cancer is the primary responsible factor for the growth of CADx market. Furthermore, advancements in digital imaging techniques, improved efficiencies of CADx solutions, ease of integration of CADx solutions with various imaging equipment and growing awareness among the patients about early detection of cancer, have boosted the overall growth of this market. Moreover, the expansion of CADx applications to newer clinical areas, active research and development activities in medical imaging, rapid transition of hospitals to promote automatic workflow integration in their current work environment and rising installation base of CADx solutions in various multispecialty hospitals, is further expected to accentuate the growth of this market in the near future. However, certain restraining factors such as lack of adequate clinical data for validating the clinical efficacy of CADx solutions in its role of early diagnosis of the disease, disinclination of healthcare professionals in accepting these solutions as a standard imaging tool and premium pricing, might hamper the growth of this market.

This research study includes an extensive analysis of the global computer aided diagnostics (CAD) market, by application, diagnostics modalities and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. Each of these segments has been analyzed on the basis of their current and future market size, considering the macro and micro environmental factors.

The global computer aided diagnostics market is forecast to reach $XX million by 2025. The CADx market broadly focuses on major application areas (oncology, cardiovascular, and neurological) and various imaging modalities (mammography, MRI, tomosynthesis, etc.). The application segment of this market comprise of oncology and other diseases (neurological, cardiovascular and musculoskeletal) application areas. The oncology segment is further sub-segmented into breast, lung, colorectal, prostate, liver and other cancer. The breast cancer acquired the highest market value of $XX million in 2016, growing at a CAGR of XX% and is anticipated to reach $XX million in 2025. However, prostate cancer is growing at the highest CAGR XX%. The reason for such a strong market share is attributed to the rising incidence of breast cancer. According to the World Cancer Research Fund International, breast cancer is the most common cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012. Further, according to National Cancer Institute, it is estimated that there will be 252,710 new cases of female breast cancer and an estimated XX people will die of this disease in 2017.

The Imaging modalities segment of this market comprise of various imaging tools such as mammography, magnetic resonance imaging (MRI), ultrasound imaging, tomosynthesis, computed tomography (CT) and others. The mammography acquired the highest market value of $XX million in 2016, growing at a CAGR of XX% and is anticipated to reach $XX million in 2025. However, the tomosynthesis imaging modalities is growing at the highest CAGR of XX%. The reason for holding such a strong market share is attributed to the continuous advancement in various digital imaging techniques, especially in mammography, MRI, tomosynthesis and computed tomography (CT).

The computer aided diagnostics market’s geographical segment comprise of North America (the U.S. and Canada), Europe (Germany, France, Italy, Spain, Poland, Netherlands, Switzerland, and Austria among others), Asia-Pacific (Japan, China, South Korea, Australia, and India among others) and RoW (Brazil, Russia and Middle East among others).  In the computer aided diagnostics market’s segment, North America dominated the market with the highest market value $XX million in 2016, growing at a CAGR of XX% and is anticipated to reach $XX million in 2025. However, the Asia-Pacific region is expected to grow at a highest CAGR of XX%.

The key players in the global computer aided diagnostics (CAD) market are Hologic Corporation, GE Healthcare, Invivo Corporation, ICADx Inc., Cadens Imaging, Siemens Healthcare, EDDA Technology and Agfa-Gevaert group. The market players are getting into the strategies such as collaborations, partnership & joint ventures, business expansion & contracts, product launches & developments, patents approvals & certifications, and mergers & acquisitions among others. The growing research and development, investments to integrate CADx with 3D imaging, rising demand for automated image analysis techniques and growing impact of cloud based solutions, are predicted to emerge as the potential growth drivers for the computer aided diagnostics market in the near future.

Note: Product cover images may vary from those shown
5 of 7
  •  Agfa Healthcare
  •  Cadens Medical Imaging
  •  EDDA Technology, Inc
  •  Fujifilm Holdings Corporation
  •  GE Healthcare
  •  Hologic Inc
  •  iCAD Inc
  •  Invivo Corporation
  •  Koninklijke Philips NV
  •  McKesson Corporation
  •  Median Technologies
  •  Merge Healthcare Inc
  •  Neusoft Corporation
  •  Parascript LLC
  •  Riverain Technologies
  •  Samsung Medison Co Ltd
  •  Siemens Healthineers
  •  Xinapse Systems Ltd
Note: Product cover images may vary from those shown
6 of 7
7 of 7
Note: Product cover images may vary from those shown
Adroll
adroll